BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38148710)

  • 1. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis.
    Liao SW; Zhan JQ; Liu CT; Yu HT; Wen MJ
    Am J Clin Oncol; 2024 Jan; 47(1):30-39. PubMed ID: 38148710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.
    Zhao J; Zhu J; Sun R; Huang C; Yuan R; Zhu Z
    BMC Cancer; 2021 May; 21(1):503. PubMed ID: 33957871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis.
    Li C; Su D; Peng J; Fang Y; Zhou W; Li S; Luo B; Wan D; Pan Z
    Ann Palliat Med; 2019 Nov; 8(5):690-697. PubMed ID: 31735042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Tumor Resection Plus Chemotherapy versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis.
    Li Y; Cheng X; Zhong C; Yuan Y
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629673
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases.
    Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P
    Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer.
    Ishibashi K; Ishida H; Ohsawa T; Okada N; Kumamoto K; Haga N
    Tech Coloproctol; 2013 Feb; 17(1):51-7. PubMed ID: 22936589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram to predict which patients with colorectal cancer liver metastases would benefit from primary tumor resection.
    He M; Jia Z; Hu L; Wu H
    Int J Colorectal Dis; 2023 May; 38(1):144. PubMed ID: 37237238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis.
    Zhao J; Zhu J; Huang C; Yuan R; Zhu Z
    Acta Chir Belg; 2023 Apr; 123(2):132-147. PubMed ID: 34278951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer.
    Park JS; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Medicine (Baltimore); 2015 Apr; 94(15):e658. PubMed ID: 25881840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
    Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.
    Zhang RX; Ma WJ; Gu YT; Zhang TQ; Huang ZM; Lu ZH; Gu YK
    World J Surg Oncol; 2017 Jul; 15(1):138. PubMed ID: 28750680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
    Reynolds IS; Cromwell PM; Hoti E
    Am J Surg; 2021 Sep; 222(3):529-535. PubMed ID: 33750573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features of colorectal mucinous adenocarcinoma].
    Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China.
    Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J
    Front Oncol; 2024; 14():1335678. PubMed ID: 38380362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.